Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06347172 · ClinicalTrials.gov registry record · NA

Deprescribing in Patients Living With Dementia With Caregiver and Provider Nudges

A NA study, sponsored by Brigham and Women's Hospital.

Completed
Registry status
NA
Development phase
250
Enrollment target

NCT06347172: Completed NA study, sponsored by Brigham and Women's Hospital.

NCT06347172 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 250 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06347172, a NA study, has completed, sponsored by Brigham and Women's Hospital.

COMPLETED
Registry status
NA
Development phase
250 participants
Enrollment target

Study Summary

The objectives of this study are to demonstrate the feasibility of implementing a deprescribing nudge intervention using pragmatic methods, confirm that outcomes can be feasibly measured and evaluated at scale in a subsequent embedded pragmatic clinical trial (ePCT), and explore representativeness of persons living with dementia and care partners identified.

Primary Outcome

This is the primary progression criteria for the study, measured on the patient level. This is measured as a composite of the number of eligible PCPs or their PLWD/care partners who view or click on information on or before the primary care provider visit, up to 10 days

Interventions

  • BEHAVIORAL Nudge Intervention

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2024-08-01
Est. Completion 2025-12-15
Phase NA
Brigham and Women's Hospital

937 total trials

What the finished NCT06347172 record still lists

NCT06347172 is an interventional study that assigns participants to a tested intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower).

The record links to 0 conditions, and to 1 intervention - of which Nudge Intervention is the first listed.

NCT06347172 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06347172 about?

NCT06347172 is a clinical study titled "Deprescribing in Patients Living With Dementia With Caregiver and Provider Nudges". The objectives of this study are to demonstrate the feasibility of implementing a deprescribing nudge intervention using pragmatic methods, confirm that outcomes can be feasibly measured and evaluated at scale in a subsequent embedded pragmatic clinical trial (ePCT), and explore representativeness o...

What is the current status of trial NCT06347172?

This trial is currently completed. It is a NA study. The enrollment target is 250 participants. The study started on 2024-08-01. Estimated completion is 2025-12-15.

What interventions are being tested in trial NCT06347172?

The interventions under investigation include: Nudge Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT06347172?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06347172's enrollment target sits among peer trials

250 410th of 2000 higher than 1,567 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00483249 · 250 participants · NA

    Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm

  • NCT00777712 · 250 participants

    Mechanisms Underlying Impaired Diabetic Wound Healing

  • NCT01451502 · 250 participants · NA

    Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units

  • NCT01771718 · 250 participants

    Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06347172, the US trial registry maintained by the National Library of Medicine. NCT06347172 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.